Inventor · disambiguated record
Chia-Ying Kao Lam
Also filed as: LAM CHIA-YING KAO
14 granted patents·8 pending applications·47 citations·filing 2014–2025
90Inventor score
Top patents by PatentIndex Score
22 records- 0194US10647768B2Multi-chain polypeptide-containing tri-specific binding moleculesMACROGENICS INC·Filed 2015·Granted May 12, 2020·19 cites·21 claims
- 0291US11421031B2Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereofMACROGENICS INC·Filed 2020·Granted Aug 23, 2022·2 cites·22 claims
- 0389US11685781B2Variant CD3-binding domains and their use in combination therapies for the treatment of diseaseMACROGENICS INC·Filed 2019·Granted Jun 27, 2023·4 cites·33 claims
- 0489US11459394B2Bispecific binding molecules that are capable of binding CD137 and tumor antigens, and uses thereofMACROGENICS INC·Filed 2018·Granted Oct 4, 2022·4 cites·8 claims
- 0587US11942149B2Bispecific binding molecules that are capable of binding CD137 and tumor antigens, and uses thereofMACROGENICS INC·Filed 2022·Granted Mar 26, 2024·1 cites·14 claims
- 0686US11802155B2ILT-binding agents and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2021·Granted Oct 31, 2023·1 cites·34 claims
- 0786US10633443B2Bi-specific monovalent diabodies that are capable of binding CD19 and CD3, and uses thereofMACROGENICS INC·Filed 2015·Granted Apr 28, 2020·3 cites·9 claims
- 0885US2024182559A1MULTl-CHAIN POLYPEPTIDE-CONTAINING TRI-SPECIFIC BINDING MOLECULES THAT SPECIFICALLY BIND TO MULTIPLE CANCER ANTIGENSMACROGENICS INC·Filed 2023·Application pending·0 cites
- 0984US11639386B2Bi-specific monovalent diabodies that are capable of binding CD19 and CD3, and uses thereofMACROGENICS INC·Filed 2020·Granted May 2, 2023·1 cites·10 claims
- 1084US9908938B2Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereofMACROGENICS INC·Filed 2014·Granted Mar 6, 2018·6 cites·27 claims
- 1184US2025313628A1Bi-specific monovalent diabodies that are capable of binding cd19 and cd3, and uses thereofMACROGENICS INC·Filed 2025·Application pending·0 cites
- 1283US11820818B2Multi-chain polypeptide-containing tri-specific binding moleculesMACROGENICS INC·Filed 2020·Granted Nov 21, 2023·1 cites·16 claims
- 1383US10717778B2Bispecific molecules comprising an HIV-1 envelope targeting armUNIV DUKE·Filed 2015·Granted Jul 21, 2020·3 cites·20 claims
- 1482US12173051B2Bispecific molecules comprising an HIV-1 envelope targeting armUNIV DUKE·Filed 2020·Granted Dec 24, 2024·1 cites·16 claims
- 1581US2023399399A1Bi-Specific Monovalent Diabodies That are Capable of Binding CD19 and CD3, and Uses ThereofMACROGENICS INC·Filed 2023·Application pending·0 cites
- 1679US10730947B2Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereofMACROGENICS INC·Filed 2018·Granted Aug 4, 2020·1 cites·18 claims
- 1778US12410251B2ILT-binding agents and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2023·Granted Sep 9, 2025·0 cites·27 claims
- 1877US2023167178A1Bispecific Molecules That Are Immunoreactive With Immune Effector Cells That Express An Activating Receptor And An Antigen Expressed By A Cell Infected By A Virus And Uses ThereofMACROGENICS INC·Filed 2022·Application pending·0 cites
- 1972US2024043537A1Variant CD3-Binding Domains and Their Use in Combination Therapies for the Treatment of DiseaseMACROGENICS INC·Filed 2023·Application pending·0 cites
- 2071US2024233818A1Bispecific binding molecules that are capable of binding cd137 and tumor antigens, and uses thereofMACROGENICS INC·Filed 2024·Application pending·0 cites
- 2147US2021246194A1Optimized gp41-Binding Molecules and Uses ThereofMACROGENICS INC·Filed 2019·Application pending·0 cites
- 2241US2017157251A1Bi-Specific Monovalent Diabodies That are Capable of Binding CD19 and CD3, and Uses ThereofMACROGENICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chia-Ying Kao Lam files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →